204 related articles for article (PubMed ID: 28682435)
21. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
22. Long Non-Coding RNA (lncRNA) X-Inactive Specific Transcript (XIST) Plays a Critical Role in Predicting Clinical Prognosis and Progression of Colorectal Cancer.
Zhang XT; Pan SX; Wang AH; Kong QY; Jiang KT; Yu ZB
Med Sci Monit; 2019 Aug; 25():6429-6435. PubMed ID: 31452526
[TBL] [Abstract][Full Text] [Related]
23. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
Dong Z; Wang Y
Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
[TBL] [Abstract][Full Text] [Related]
24. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
25. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.
Wang Q; Chen Q
J Cancer Res Ther; 2018 Jun; 14(Supplement):S405-S409. PubMed ID: 29970697
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
Zhang JJ; Yang P; Shang XQ
Zhongguo Gu Shang; 2023 Jun; 36(6):559-64. PubMed ID: 37366099
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
Cui WC; Wu YF; Qu HM
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
[TBL] [Abstract][Full Text] [Related]
28. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
Yang Y; Fei M; Zhou X; Li Y; Jin D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
[No Abstract] [Full Text] [Related]
29. Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2.
Ruan J; Zheng L; Hu N; Guan G; Chen J; Zhou X; Li M
Arch Biochem Biophys; 2018 May; 646():128-136. PubMed ID: 29608878
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA Sox4 promotes proliferation and migration by activating Wnt/β-catenin signaling pathway in osteosarcoma.
Tian Z; Yang G; Jiang P; Zhang L; Wang J; Sun S
Pharmazie; 2017 Sep; 72(9):537-542. PubMed ID: 29441981
[TBL] [Abstract][Full Text] [Related]
31. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo.
Qiao S; Qi K; Liu C; Xu C; Ma J; Xu X; Li C; Wang Z
J Clin Lab Anal; 2020 May; 34(5):e23164. PubMed ID: 31893577
[TBL] [Abstract][Full Text] [Related]
32. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
Qu G; Ma Z; Tong W; Yang J
Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
[TBL] [Abstract][Full Text] [Related]
33. CCEPR is a novel clinical biomarker for prognosis and regulates cell proliferation through PCNA in osteosarcoma.
Teng J; Guo X; Wang H
J Cell Biochem; 2019 Aug; 120(8):12796-12802. PubMed ID: 30861164
[TBL] [Abstract][Full Text] [Related]
34. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Zhang SZ; Cai L; Li B
Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
[TBL] [Abstract][Full Text] [Related]
35. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
Yang Y; Wang S; Li T
Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
[TBL] [Abstract][Full Text] [Related]
36. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
37. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
Li Z; Tang Y; Xing W; Dong W; Wang Z
Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
[TBL] [Abstract][Full Text] [Related]
38. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
Cong M; Li J; Jing R; Li Z
Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
[TBL] [Abstract][Full Text] [Related]
40. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
Uzan VR; Lengert Av; Boldrini É; Penna V; Scapulatempo-Neto C; Scrideli CA; Filho AP; Cavalcante CE; de Oliveira CZ; Lopes LF; Vidal DO
PLoS One; 2016; 11(6):e0156774. PubMed ID: 27253450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]